Home TNAX Biopharma

TNAX Biopharma

In operation
-
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

TNAX Biopharma is a developer of pharmaceuticals aimed at improving patients' quality of life. The company’s drugs provide novel antibody therapies that target the interaction between immune receptors and their ligands, enabling patients to receive the treatments needed for refractory diseases.
TNAX Biopharma Corp.
Tokyo,Tokyo,Japan
101~500 people
January 01, 2018
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs Monoclonal Antibody